These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25238640)

  • 41. Efficient synthetic access to a new family of highly potent bryostatin analogues via a Prins-driven macrocyclization strategy.
    Wender PA; Dechristopher BA; Schrier AJ
    J Am Chem Soc; 2008 May; 130(21):6658-9. PubMed ID: 18452292
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Function through synthesis-informed design.
    Wender PA; Quiroz RV; Stevens MC
    Acc Chem Res; 2015 Mar; 48(3):752-60. PubMed ID: 25742599
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bryostatin 1 Promotes Synaptogenesis and Reduces Dendritic Spine Density in Cortical Cultures through a PKC-Dependent Mechanism.
    Ly C; Shimizu AJ; Vargas MV; Duim WC; Wender PA; Olson DE
    ACS Chem Neurosci; 2020 Jun; 11(11):1545-1554. PubMed ID: 32437156
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: dissociation of activities using 26-epi-bryostatin 1.
    Szallasi Z; Du L; Levine R; Lewin NE; Nguyen PN; Williams MD; Pettit GR; Blumberg PM
    Cancer Res; 1996 May; 56(9):2105-11. PubMed ID: 8616857
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A simple analogue of tumor-promoting aplysiatoxin is an antineoplastic agent rather than a tumor promoter: development of a synthetically accessible protein kinase C activator with bryostatin-like activity.
    Nakagawa Y; Yanagita RC; Hamada N; Murakami A; Takahashi H; Saito N; Nagai H; Irie K
    J Am Chem Soc; 2009 Jun; 131(22):7573-9. PubMed ID: 19449873
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design, synthesis, and biological evaluation of a potent, PKC selective, B-ring analog of bryostatin.
    Wender PA; Verma VA
    Org Lett; 2006 Apr; 8(9):1893-6. PubMed ID: 16623578
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New approaches to the total synthesis of the bryostatin antitumor macrolides.
    Hale KJ; Manaviazar S
    Chem Asian J; 2010 Apr; 5(4):704-54. PubMed ID: 20354984
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isolation, analytical measurements, and cell line studies of the iron-bryostatin-1 complex.
    Plummer S; Manning T; Baker T; McGreggor T; Patel M; Wylie G; Phillips D
    Bioorg Med Chem Lett; 2016 May; 26(10):2489-2497. PubMed ID: 27068183
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.
    Szallasi Z; Denning MF; Smith CB; Dlugosz AA; Yuspa SH; Pettit GR; Blumberg PM
    Mol Pharmacol; 1994 Nov; 46(5):840-50. PubMed ID: 7969070
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Total synthesis of bryostatin 16 using atom-economical and chemoselective approaches.
    Trost BM; Dong G
    Nature; 2008 Nov; 456(7221):485-8. PubMed ID: 19037312
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Binding of [26-3H]bryostatin 1 and analogs to calcium-dependent and calcium-independent protein kinase C isozymes.
    Kazanietz MG; Lewin NE; Gao F; Pettit GR; Blumberg PM
    Mol Pharmacol; 1994 Aug; 46(2):374-9. PubMed ID: 8078499
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bryostatin modulates latent HIV-1 infection via PKC and AMPK signaling but inhibits acute infection in a receptor independent manner.
    Mehla R; Bivalkar-Mehla S; Zhang R; Handy I; Albrecht H; Giri S; Nagarkatti P; Nagarkatti M; Chauhan A
    PLoS One; 2010 Jun; 5(6):e11160. PubMed ID: 20585398
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Binding of [3H]bryostatin 4 to protein kinase C.
    Lewin NE; Dell'Aquila ML; Pettit GR; Blumberg PM; Warren BS
    Biochem Pharmacol; 1992 May; 43(9):2007-14. PubMed ID: 1596288
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bryostatin-1 vs. TPPB: dose-dependent APP processing and PKC-α, -δ, and -ε isoform activation in SH-SY5Y neuronal cells.
    Yi P; Schrott L; Castor TP; Alexander JS
    J Mol Neurosci; 2012 Sep; 48(1):234-44. PubMed ID: 22700373
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the antitumor activity of bryostatins 1, 5, and 8.
    Kraft AS; Woodley S; Pettit GR; Gao F; Coll JC; Wagner F
    Cancer Chemother Pharmacol; 1996; 37(3):271-8. PubMed ID: 8529289
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bryostatin activates HIV-1 latent expression in human astrocytes through a PKC and NF-ĸB-dependent mechanism.
    Díaz L; Martínez-Bonet M; Sánchez J; Fernández-Pineda A; Jiménez JL; Muñoz E; Moreno S; Álvarez S; Muñoz-Fernández MÁ
    Sci Rep; 2015 Jul; 5():12442. PubMed ID: 26199173
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bryostatin-1 synergizes with histone deacetylase inhibitors to reactivate HIV-1 from latency.
    Pérez M; de Vinuesa AG; Sanchez-Duffhues G; Marquez N; Bellido ML; Muñoz-Fernandez MA; Moreno S; Castor TP; Calzado MA; Muñoz E
    Curr HIV Res; 2010 Sep; 8(6):418-29. PubMed ID: 20636281
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of bryostatin 1 and other pharmacological activators of protein kinase C on 1-[beta-D-arabinofuranosyl]cytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells.
    Jarvis WD; Povirk LF; Turner AJ; Traylor RS; Gewirtz DA; Pettit GR; Grant S
    Biochem Pharmacol; 1994 Mar; 47(5):839-52. PubMed ID: 8135859
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Convergent assembly of highly potent analogues of bryostatin 1 via pyran annulation: bryostatin look-alikes that mimic phorbol ester function.
    Keck GE; Kraft MB; Truong AP; Li W; Sanchez CC; Kedei N; Lewin NE; Blumberg PM
    J Am Chem Soc; 2008 May; 130(21):6660-1. PubMed ID: 18452293
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular modeling, total synthesis, and biological evaluations of C9-deoxy bryostatin 1.
    Keck GE; Poudel YB; Rudra A; Stephens JC; Kedei N; Lewin NE; Peach ML; Blumberg PM
    Angew Chem Int Ed Engl; 2010 Jun; 49(27):4580-4. PubMed ID: 20491108
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.